MMP2 and cancer: As shown in Figure 3C, treatment with Iso at both concentrations results in a decrease in proteolytic activity, demonstrated by accumulation of MMP9 proteases in cancer cells, and also by decreased proteolytic fractions of 72 kDa (proMMP2) and active MMP2 (66 kDa).